FDA Import Refusal 799-4813455-7/11/3 — Cipla Ltd.
The FDA refused shipment 799-4813455-7/11/3 from Cipla Ltd. (India) on Dec 26, 2024. The refused product falls under Drugs and Biologics — NAPROXEN (ANTI-INFLAMMATORY). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 26, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GCY49 NAPROXEN (ANTI-INFLAMMATORY)
- Charges
- 118,75